About: Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $12.31 (-7.09%)
IMMXNASDAQImmix Biopharma Inc
Loading watchlist status…
Immix Biopharma Inc share price
IMMX price activity
Last Price
$12.310
Change (24hr)
-0.94 USD (-7.09%)
Volume
1.28M
Volume (4w avg)
-
Open
$13.12
Day Range
$12.24 - $13.23
Previous Close
$13.25
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
IMMX price performance
-11.82%
5D
26.65%
1M
135.37%
YTD
439.91%
1Y
Delayed
09 Sep, 8:00 pm GMT+0
IMMX Market Signals